Inventor · disambiguated record
Karl-Heinz Altmann
Also filed as: ALTMANN KARL-HEINZ
23 granted patents·7 pending applications·3,216 citations·filing 1993–2013
97Inventor score
Top patents by PatentIndex Score
30 records- 0198US5700920ACarbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediatesNOVARTIS AG·Filed 1995·Granted Dec 23, 1997·1.1k cites·37 claims
- 0298US5610300ACarbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediatesCIBA GEIGY CORP·Filed 1995·Granted Mar 11, 1997·1.2k cites·16 claims
- 0396US6258812B1Phthalazines with angiogenesis inhibiting activityNOVARTIS AG·Filed 1998·Granted Jul 10, 2001·206 cites·30 claims
- 0495US6451991B1Sugar-modified gapped oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1997·Granted Sep 17, 2002·244 cites·14 claims
- 0595US6448277B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2001·Granted Sep 10, 2002·64 cites·19 claims
- 0694US6878720B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2002·Granted Apr 12, 2005·50 cites·16 claims
- 0793US6387927B1Epothilone derivatives and their use as antitumor agentsNOVATIS AG·Filed 2001·Granted May 14, 2002·83 cites·16 claims
- 0891US6350878B1Intermediates for the synthesis of epothilones and methods for their preparationNOVARTIS AG·Filed 2000·Granted Feb 26, 2002·34 cites·9 claims
- 0989US7002022B2N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGFSCHERING AG·Filed 2004·Granted Feb 21, 2006·24 cites·8 claims
- 1088US5744460ACombination for treatment of proliferative diseasesNOVARTIS AG·Filed 1996·Granted Apr 28, 1998·89 cites·12 claims
- 1187US6710047B2Phthalazines with angiogenesis inhibiting activityNOVARTIS AG·Filed 2003·Granted Mar 23, 2004·25 cites·4 claims
- 1285US6608071B2Isoquinoline derivatives with angiogenesis inhibiting activityNOVARTIS AG·Filed 2001·Granted Aug 19, 2003·24 cites·12 claims
- 1383US6514974B2Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activityNOVARTIS AG·Filed 2001·Granted Feb 4, 2003·15 cites·8 claims
- 1481US6670468B12′-substituted nucleosides and oligonucleotide derivativesNOVARTIS AG·Filed 2001·Granted Dec 30, 2003·12 cites·4 claims
- 1574US5919773AAntisense oligonucleotide modulation of raf gene expressionISIS PHARMACEUTICALS INC·Filed 1997·Granted Jul 6, 1999·28 cites·4 claims
- 1669US2009191264A1Epothilone compositionsSONNTAG JEAN-CLAUDE·Filed 2009·Application pending·0 cites
- 1768US7358266B2Cyclopropyl and cyclobutyl epothilone analogsSCRIPPS RESEARCH INST·Filed 2002·Granted Apr 15, 2008·5 cites·23 claims
- 1861US2005042275A1Epothilone compositionsFiled 2004·Application pending·0 cites
- 1959US7825141B2Epothilone derivativesNOVARTIS AG·Filed 2005·Granted Nov 2, 2010·0 cites·3 claims
- 2059US5744362AAntisense oligonucleotide modulation of raf gene expressionISIS PHARMACEUTICALS INC·Filed 1995·Granted Apr 28, 1998·12 cites·7 claims
- 2157US6291668B1Oligonucleotide derivativesNOVARTIS AG·Filed 1998·Granted Sep 18, 2001·21 cites·2 claims
- 2257US2006074112A1N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitorsALTMANN KARL-HEINZ·Filed 2005·Application pending·0 cites
- 2354US2005159374A12'-Substituted nucleosides and oligonucleotide derivativesFiled 2003·Application pending·0 cites
- 2452US5948898AMethoxyethoxy oligonucleotides for modulation of protein kinase C expressionISIS PHARMACEUTICALS INC·Filed 1996·Granted Sep 7, 1999·9 cites·4 claims
- 2551US2011009459A1Epothilone derivativesNOVARTIS AG·Filed 2010·Application pending·0 cites
- 2649US2010022596A1Epothilone analoguesALTMANN KARL-HEINZ·Filed 2007·Application pending·0 cites
- 2747US5461152ACarbocyclic nucleosides containing bicycle rings, oligonucleotides therefrom, process for their preparation, their use and intermediatesCIBA GEIGY CORP·Filed 1993·Granted Oct 24, 1995·3 cites·13 claims
- 2840US6329519B1Intermediates for oligonucleotide synthesisISIS PHARMACEUTICALS INC·Filed 1997·Granted Dec 11, 2001·3 cites·24 claims
- 2940US6153599AMethoxyethoxy oligonucleotides for modulation of protein kinase C expressionISIS PHARMACEUTICALS INC·Filed 1997·Granted Nov 28, 2000·4 cites·9 claims
- 3039US2015246907A1Pyridomycin based compounds exhibiting an antitubercular activityETH ZUERICH·Filed 2013·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →